Lung Cancer
EA5191
A Randomized Phase II Trial of Cabozantinib and Cabozantinib plus Nivolumab versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
Physician and Research Staff Educational Material
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Physician Fact Sheet
